Threadneedle American Fund

Similar documents
Threadneedle UK Institutional Fund

Threadneedle UK Smaller Companies Fund

Threadneedle American Smaller Companies Fund (US)

Threadneedle UK Monthly Income Fund

Threadneedle UK Select Fund

Threadneedle European Smaller Companies Fund

Threadneedle High Yield Bond Fund

Threadneedle American Fund

Threadneedle UK Equity Income Fund

Threadneedle UK Equity Income Fund

Threadneedle UK Mid 250 Fund

Threadneedle European Select Fund

Threadneedle UK Extended Alpha Fund

Threadneedle Asia Fund

Threadneedle Global Bond Fund

Threadneedle Navigator Growth Managed Trust

Threadneedle Sterling Fund

Threadneedle Absolute Return Bond Fund

Threadneedle Global Equity Income Fund

Threadneedle Dynamic Real Return Fund

Threadneedle Global Emerging Markets Equity Fund

Threadneedle Sterling Fund

Threadneedle Latin America Fund

Threadneedle Emerging Market Bond Fund

Threadneedle UK Property Authorised Investment Fund

Threadneedle European Bond Fund

Threadneedle Navigator Growth Trust

Threadneedle Global Select Fund

Threadneedle Navigator UK Index Tracker Trust

Threadneedle Navigator Cautious Managed Trust

Threadneedle UK Property Authorised Investment Fund

Threadneedle Emerging Market Local Fund

Threadneedle Managed Equity Fund

Threadneedle Managed Bond Focused Fund

Threadneedle Navigator Growth Managed Trust

Threadneedle European Corporate Bond Fund

Threadneedle Managed Equity & Bond Fund

PORTFOLIO ADVANTAGE FUNDS ICVC

Threadneedle Managed Bond Fund

Threadneedle Global Extended Alpha Fund

Threadneedle Absolute Return Bond Fund

Threadneedle UK Property Authorised Investment Fund

Threadneedle Navigator Income Trust

Threadneedle European Bond Fund

Threadneedle Credit Opportunities Fund

THREADNEEDLE MANAGED EQUITY INCOME FUND

INDEX LINKED GILTS UNIT TRUST

Aberdeen Multi-Asset Growth 2 Portfolio

Baring Japan Growth Trust Barings German Growth Trust

SHAREHOLDER CIRCULAR

The Virgin Bond, Gilt and UK Share Fund. Interim Report and Financial Statements For the six month period ended 31 January 2018 (unaudited)

Aberdeen Foundation Growth Fund

Morgan Stanley Funds (UK)

Interim Report & Financial Statements. WAY Momentum Portfolio. For the six months ended 31 August 2018 (unaudited)

Interim Report & Financial Statements. FP Frontier ICVC. For the six months ended 30 November 2018 (unaudited)

JPM Strategic Bond Fund

Prospectus. Standard Life Investment Company II

HIGH OCTANE UNIT TRUST

(Authorised and regulated by the Financial Conduct Authority) (Authorised and regulated by the Financial Conduct Authority)

Aberdeen Diversified Growth Fund

JPM Global High Yield Bond Fund

INDEX LINKED GILTS UNIT TRUST

PROSPECTUS 6 April 2017 THREADNEEDLE INVESTMENT FUNDS II ICVC

Omnis Portfolio Investments ICVC

GILTS UNIT TRUST FOR THE PERIOD ENDING 30 SEPTEMBER 2016

Aberdeen Foundation Growth Fund

Short report For the year ended 31 Dec 2016

INDEX LINKED GILTS UNIT TRUST

RBS INVESTMENT OPTIONS ICVC PROSPECTUS

Aberdeen Investment Funds ICVC

AVIVA INVESTORS MANAGER OF MANAGER ICVC (ICVC2)

RBS STAKEHOLDER INVESTMENT FUND ICVC PROSPECTUS

Schroder Unit Trusts Limited Prospectus

THREADNEEDLE INVESTMENT FUNDS ICVC

Throughout this letter, and in the enclosed documents, we refer to these funds as the Existing Funds.

PROSPECTUS 6 April 2017 THREADNEEDLE FOCUS INVESTMENT FUNDS ICVC

WESLEYAN INTERNATIONAL TRUST FINAL SHORT REPORT FOR THE YEAR ENDED 31 MARCH 2016

Prospectus Invesco Diversified Balanced Risk Investment Series. 1 October 2018

Omnibus Prospectus Invesco UK Authorised Investment Companies with Variable Capital

THREADNEEDLE MANAGED FUNDS

Aberdeen Investment Funds ICVC

Standard Life Investments Ignis American Growth Fund. Standard Life Investments Ignis Balanced Growth Fund

Aberdeen World Equity Enhanced Index Fund

GILTS UNIT TRUST FOR THE YEAR ENDING 31 MARCH 2015

(Intermediary) Schroder Unit Trusts Limited Prospectus 3 September 2018

Aberdeen Asia Pacific Equity Enhanced Index Fund

Schroder Unit Trusts Limited. Prospectus. (relating to the Schroder Multi-Manager Funds) 12 March United Kingdom

PROSPECTUS 22 December 2017 THREADNEEDLE INVESTMENT FUNDS ICVC

Zurich Investment Funds ICVC. Interim Report & Accounts (unaudited) for the period ended 30 November 2017

FOCUS INVESTMENT FUNDS ICVC

THREADNEEDLE UK EQUITY FUND RANGE INCOME STRATEGIES

MI Activus Wealth Funds - MI Activus Investment Fund

HENDERSON INVESTMENT FUNDS LIMITED. Prospectus prepared in accordance with the Collective Investment Schemes Sourcebook. for

Schroder Absolute Return Fund Company Prospectus. (SARFCO) 25 May United Kingdom

Schroder Asian Income Maximiser. Final Short Report 1 January 2016 to 31 December 2016

Growth Trust. Manager s Half-Year Short Report 2013

FP Verbatim Portfolio 5 Growth Fund

BlackRock Cash Fund. Objectives and Investment Policy. Risk and Reward Profile KEY INVESTOR INFORMATION. Class OS Accumulating GBP

THREADNEEDLE INVESTMENT FUNDS ICVC

Supplementary Information Document. Legg Mason Funds ICVC

Transcription:

Annual Short Report 7 March 2018 Fund Manager s Report Nadia Grant Performance of Class 1 Accumulation shares* Over the twelve months to 7 March 2018, the published share price of Class 1 Accumulation shares in the has risen from 270.71p to 282.61p. Looking at the sterling performance within its peer group, the total return on the fund for the twelve months ending 28 February 2018, including net reinvested income, is +9.07% as compared to a sector median return of +4.97% over the same period. (For information the S&P 500 Composite Index returned +5.76% over the same period). Market Overview and Portfolio Activity The S&P 500 made solid gains in US dollar terms during the period, consistently hitting record highs and climbing in every month apart from February 2018. Earlier in the period, the Federal Reserve raised interest rates by 25 basis points in June, maintaining its forecast for another hike in 2017 (which ultimately materialised in December) and three in 2018. However, stronger-than-expected corporate earnings and dovish commentary from the Federal Reserve propelled the market to record highs. US markets also finished 2017 strongly, benefiting from betterthan-expected corporate results and GDP figures, buoyant consumer confidence and strong employment data. US equities received further support from anticipation that Congress would approve President Trump s flagship tax-cutting bill. The bill, which was eventually passed on 20 December, features a permanent cut in corporation tax from 35% to 21% and smaller temporary reductions in income taxes. February saw US (and global) equities finally snap their record-breaking run of monthly gains. Treasuries and equities sold off at the start of the month as stronger-than-expected US wage growth stoked fears of higher inflation and, in turn, faster interest-rate hikes. During the period, key new positions included Union Pacific (railways), L3 Technologies (defence), MasterCard (financial services), Biogen (pharmaceuticals) and Citizens Financial Group (banking). Union Pacific has a strong and improving free cashflow, which has been boosted by tax reform in the US. The company is also benefiting from strong demand for freight services, a development that should ultimately also deliver pricing benefits. *In pound Sterling and against UK peer group. Changes to L3 Technologies management are beginning to pay off, with signs of improved execution and stronger guidance for 2018. The company should also be a key beneficiary of mid-single-digit growth in federal outlays as US defence spending picks up. In our view, though it continues to trade at a solid discount to its peers, L3 is the only prime defence stock with a legitimate case for multi-year margin improvement. MasterCard continues to enjoy compound growth, thanks largely to its exposure to positive industry trends in software-driven payments, e-commerce and international penetration. The company is also benefiting from the ongoing move from cash to card payments. MasterCard is aiming for longer-term revenue growth of 7% to 9%, mid-teens growth in earnings-per-share, and significant expansion of its margins. In our view, among large-cap companies, Biogen offers the greatest visibility on a set of catalysts that could significantly re-rate its shares in the future. We feel that the company s pipeline is not sufficiently priced into the stock, and Biogen stands a reasonable chance of bringing an innovative disease-modifying therapy, aducanumab, to market for the treatment of Alzheimer s disease. A regional bank with branches in the New England and mid-atlantic regions, Citizens Financial Group has strong capital ratios, midsingle-digit revenue growth and strong credit quality, coupled with an attractive valuation relative to its peers. The company has shown progress in controlling its expenses, and has further opportunities for margin expansion through reducing costs. We switched our utilities exposure from PG&E to Xcel Energy. Our thesis for PG&E played out, and we view Xcel as a high quality firm whose management consistently delivers on its promises. The company also benefits from high earnings visibility, as Minnesota rates have been set for the next four years. Yet despite higher quality, visibility and growth potential, the stock is currently trading in line with regulated peers. Also during the period, we exited names including Southwest Airlines, Johnson & Johnson, Lockheed Martin and Thermo Fisher Scientific. Looking ahead, the backdrop remains very supportive for US equities. US stocks are set to benefit domestically from a strong economic momentum that is further boosted by tax reforms and, internationally, from a synchronised global recovery. Fund Facts Fund Accounting and Distribution Dates Accounting Dates Payment Dates 7 March 7 May Ongoing Charges Figure The Ongoing Charges Figure (OCF) is the European standard method of disclosing the charges of a share class of a fund based on the financial year s expenses and may vary from year to year. It includes charges such as the fund s annual management charge, registration fee, custody fees and distribution cost but ordinarily excludes the costs of buying or selling assets for the fund (unless these assets are shares of another fund). Where published, the Key Investor Information Document (KIID) contains the current OCF. For a more detailed breakdown please visit columbiathreadneedle.com/fees. Share class 7 March 2018 7 March 2017 Class 1 Income shares 1.63% 1.62% Class 1 Accumulation shares 1.63% 1.62% Class 1 EUR Hedged Accumulation shares 1.63% 1.62% Class 2 Accumulation shares 1.06% 1.05% Class X Accumulation shares 0.06% 0.04% Class Z Income shares 0.83% 0.82% Class Z Accumulation shares 0.83% 0.82% Class Z EUR Hedged Accumulation shares 0.83% 0.82%

Summary of Fund Performance Performance History (%) Share class 2018 1 2017 2016 2015 2014 2013 Class 1 Income shares +0.63 +14.00 +26.81 +7.47 +17.59 +32.87 Class 1 Accumulation shares +0.62 +14.00 +26.81 +7.46 +17.58 +32.87 Class 1 EUR Hedged Accumulation shares +2.45 +22.72 +4.20 +1.83 +10.96 +35.40 Class 2 Accumulation shares +0.72 +14.65 +27.54 +8.11 +18.31 +33.70 Class X Accumulation shares +0.89 +15.80 +28.81 +9.18 +19.52 +35.04 Class Z Income shares +0.76 +14.91 +27.84 +8.35 +18.57 +33.89 Class Z Accumulation shares +0.76 +14.91 +27.83 +8.35 +18.57 +34.01 Class Z EUR Hedged Accumulation shares 2 +2.66 +23.67 +5.08 +2.81 +11.83 +9.54 1 To 28 February 2018. 2 Commenced 20 September 2013. Source: Morningstar and Threadneedle. Bid to bid prices are quoted (i.e. not including any initial charge) with net income reinvested for a UK basic rate tax payer and gross income reinvested for a non-uk resident. Performance data is quoted in sterling apart from hedged share classes, where applicable, which are in the hedged currency. Past performance is not a guide to future investment performance. The value of investments and any income is not guaranteed and can go down as well as up and may be affected by exchange rate fluctuations. This means that an investor may not get back the amount invested. Net Asset Value (NAV) As at Share class NAV ( ) NAV pence per share Number of shares in issue 7 March 2018 Class 1 Income shares 4,803,500 285.17 1,684,411 7 March 2017 Class 1 Income shares 6,091,211 270.62 2,250,851 7 March 2016 Class 1 Income shares 4,854,217 195.74 2,479,894 7 March 2018 Class 1 Accumulation shares 485,727,763 285.25 170,279,598 7 March 2017 Class 1 Accumulation shares 583,445,247 270.69 215,539,877 7 March 2016 Class 1 Accumulation shares 530,520,264 195.75 271,020,970 7 March 2018 Class 1 EUR Hedged Accumulation shares 4,750,287 312.10 1,522,027 7 March 2017 Class 1 EUR Hedged Accumulation shares 3,156,948 258.59 1,220,851 7 March 2016 Class 1 EUR Hedged Accumulation shares 3,126,754 196.48 1,591,411 7 March 2018 Class 2 Accumulation shares 1,235,583,177 321.97 383,761,073 7 March 2017 Class 2 Accumulation shares 1,000,698,144 303.79 329,406,571 7 March 2016 Class 2 Accumulation shares 940,787,459 218.43 430,711,104 7 March 2018 Class X Accumulation shares 247,115,556 345.57 71,508,964 7 March 2017 Class X Accumulation shares 159,516,420 322.85 49,409,227 7 March 2016 Class X Accumulation shares 6,895 229.83 3,000 7 March 2018 Class Z Income shares 22,354,321 240.05 9,312,193 7 March 2017 Class Z Income shares 19,864,678 227.09 8,747,635 7 March 2016 Class Z Income shares 16,342,062 164.04 9,961,959 7 March 2018 Class Z Accumulation shares 376,544,268 248.51 151,521,910 7 March 2017 Class Z Accumulation shares 393,088,989 233.96 168,018,806 7 March 2016 Class Z Accumulation shares 323,644,550 167.84 192,830,276 7 March 2018 Class Z EUR Hedged Accumulation shares 567,618 176.13 322,276 7 March 2017 Class Z EUR Hedged Accumulation shares 449,007 144.71 310,276 7 March 2016 Class Z EUR Hedged Accumulation shares 180,778 109.07 165,750

Distribution History/Share Price Range Highest share price (pence) Lowest share price (pence) Year to Share class Pence per share 7 March 2018 Class 1 Income shares 295.25 254.18 7 March 2017 Class 1 Income shares 0.0642 271.22 192.15 7 March 2016 Class 1 Income shares 202.21 171.46 7 March 2018 Class 1 Accumulation shares 295.32 254.24 7 March 2017 Class 1 Accumulation shares 0.0636 271.23 192.15 7 March 2016 Class 1 Accumulation shares 202.21 171.46 7 March 2018 Class 1 EUR Hedged Accumulation shares 323.85 245.95 7 March 2017 Class 1 EUR Hedged Accumulation shares 0.0689 258.60 193.21 7 March 2016 Class 1 EUR Hedged Accumulation shares 199.93 179.43 7 March 2018 Class 2 Accumulation shares 0.8520 333.15 285.52 7 March 2017 Class 2 Accumulation shares 1.5315 304.37 214.42 7 March 2016 Class 2 Accumulation shares 0.8683 224.46 190.75 7 March 2018 Class X Accumulation shares 4.2025 357.25 303.80 7 March 2017 Class X Accumulation shares 4.3001 323.42 225.62 7 March 2016 Class X Accumulation shares 3.1016 234.11 199.65 7 March 2018 Class Z Income shares 1.1563 249.54 213.49 7 March 2017 Class Z Income shares 1.5811 229.09 161.12 7 March 2016 Class Z Income shares 1.1066 169.37 144.05 7 March 2018 Class Z Accumulation shares 1.1913 257.09 219.95 7 March 2017 Class Z Accumulation shares 1.6177 234.39 164.76 7 March 2016 Class Z Accumulation shares 1.0589 172.12 146.39 7 March 2018 Class Z EUR Hedged Accumulation shares 0.7965 182.48 137.77 7 March 2017 Class Z EUR Hedged Accumulation shares 1.0490 144.72 107.26 7 March 2016 Class Z EUR Hedged Accumulation shares 0.5876 110.79 99.04 Past performance is not a guide to future performance.

25% 20% 15% 10% 5% 0% Classification of Investments 7 March 2018 2017 vs 7 March 2017 2016 25% 20% 7 March 2018 7 March 2017 15% 10% 5% 0% Financials Technology Portfolio Information Health care Consumer services Industrials Top Five Holdings as at 7 March 2018 % of Fund Microsoft 4.83 Apple 4.83 Amazon.com 4.14 JPMorgan Chase 3.69 Bank of America 3.32 Oil & gas Consumer goods Basic materials Utilities Collective investment schemes Net other assets Top Five Holdings as at 7 March 2017 % of Fund Apple 5.08 Alphabet Class A 4.36 Microsoft 4.19 JPMorgan Chase 3.70 Facebook 3.00

Investment Objective and Policy To achieve capital growth. The ACD s investment policy is to invest the assets of the Fund primarily in the stock of medium to large companies domiciled in North America or which have significant North American operations. If the ACD considers it desirable, it may further invest in other securities (including fixed interest securities, other equities and money market securities). Key Investor Information Document (KIID) Subscription requirements The KIID is a pre-contractual document and investors have to confirm that they have read the latest KIID before making a subscription. Threadneedle has the right to reject a subscription if the investor does not confirm that they have read the latest KIID at the time of application. Investors can obtain the latest KIID from columbiathreadneedle.com. Changes to the management of the ACD The following changes have been made to the directors of the ACD: Resignation of Mr Tim Gillbanks on 31 March 2017; Resignation of Mr Don Jordison on 1 May 2018; Appointment of Michelle Scrimgeour on 14 August 2017. Changes to the Prospectus During the period from 8 March 2017 to 7 March 2018 the following changes were made to the Prospectus of the Threadneedle Investment Funds ICVC (the Company): Introduction of co-management for the Japan Fund, and changes to the investment policy of the fund, effective from 1 November 2017; Introduction of a compulsory conversion clause effective from 1 February 2018; Change of the name of the transfer agent and the legal advisors for the Company; Reduction of fees for certain share classes from 1 February 2018; Inclusion of a definition of near cash ; Disclosures required as a result of changes to COLL as a result of the Markets in Financial Instruments Directive (MiFID II), including amendment to the description of Class 2 Shares and Class Z Shares; Disclosures relating to the UK s decision to leave the European Union ( Brexit ); Updates to include changes to the COLL rules (including PRN, changes regarding short reports, eligible markets); Updates to reflect changes being made to UK tax on distributions (gross vs net shares, as well as tax changes more generally); Updates to the list of funds managed by the ACD and the directors of the ACD; Enhanced disclosures regarding hedged share classes and performance fee calculations; Updates to performance, dilution adjustments and available share classes; Miscellaneous changes including address of the Financial Services Ombudsman, clarification on privacy statement, clarification of dividend payment dates, addresses of paying agents. Changes to the Instrument of Incorporation During the period from 8 March 2017 to 7 March 2018, the instrument of incorporation of the Company has been updated to include a compulsory conversion clause effective 1 February 2018. Brexit In June 2016 the United Kingdom voted to leave the European Union. While negotiations progress, there is significant uncertainty relating to the UK s withdrawal from the EU, the potential consequences and precise timeframe. It is expected that the UK will exit from the EU on 29 March 2019. Depending on the outcome of the UK s negotiations with the European Union, and the existence or otherwise of any formal implementation period, it is possible that the Funds may no longer be eligible to enjoy the rights set out in the UCITS Directive. Ceasing to be so eligible may affect the ability of non-uk domiciled investors to make new investments in the Company. The ACD is monitoring the situation and will keep shareholders informed. Key Risks Investment Risk: The value of investments can fall as well as rise and investors might not get back the sum originally invested. Currency Risk: Where investments are in assets that are denominated in multiple currencies, or currencies other than your own, changes in exchange rates may affect the value of the investments. Derivatives for EPM/Hedging Risk: The investment policy of the fund allows it to invest in derivatives for the purposes of reducing risk or minimising the cost of transactions. Volatility Risk: The fund may exhibit significant price volatility. Further risks applicable to the fund can be found in the Prospectus. Risk and Reward Profile As at 7 March 2018 the figure for the risk and reward profile disclosed in the most recent KIID representing this fund is 5. The fund is in this specific category because historically it has shown a medium to high level of volatility (how much the value of the fund went up and down compared to other categories). It is based on past performance data in pound sterling. If your investment in the fund is not in pound sterling, please check the figure for the risk and reward profile disclosed on our website (columbiathreadneedle.com) according to the currency of your investment in the fund.

General Information The information in this report is designed to enable shareholders to make an informed judgement on the activities of the fund during the period it covers and the results of those activities at the end of the period. For further information, please contact Threadneedle Investment Services Limited. The Long Form Report and Financial Statements is available free of charge on request from the ACD and on our website. For more information about the activities and performance of the Company during the period and previous periods, please contact the ACD at the administration address noted below, or visit our website at columbiathreadneedle.com. Contacts: Registered Office Cannon Place 78 Cannon Street London EC4N 6AG Authorised Corporate Director (ACD) Threadneedle Investment Services Limited Cannon Place 78 Cannon Street London EC4N 6AG Registrar Threadneedle Investment Services Limited Delegated to: DST Financial Services Europe Limited** Authorised and regulated by the Financial Conduct Authority (FCA) St Nicholas Lane Basildon Essex SS15 5FS Investment Manager Threadneedle Asset Management Limited Cannon Place 78 Cannon Street London EC4N 6AG Authorised Corporate Director Client Services Details UK Investors Address: Threadneedle Investment Services Limited PO Box 10033 Chelmsford Essex CM99 2AL Telephone (dealing & customer enquiries): 0800 953 0134* Fax (dealing): 0845 113 0274 Email (enquiries): questions@service.columbiathreadneedle.co.uk Asian Investors Address: Threadneedle Investment Services Limited International Financial Data Services 47, avenue JF Kennedy L-1855 Luxembourg Telephone (dealing & customer enquiries): +352 2452 9817* Fax (dealing): +352 2452 9807 Email (enquiries): threadneedleenquiries@statestreet.com All Other Investors Address: Threadneedle Investment Services Limited International Financial Data Services 47, avenue JF Kennedy L-1855 Luxembourg Telephone (dealing & customer enquiries): +352 464 010 7020* Fax (dealing): +352 2452 9807 Email (enquiries): questions@service.columbiathreadneedle.co.uk Website: columbiathreadneedle.com Depositary Citibank Europe plc, UK branch (Authorised by the Prudential Regulatory Authority (PRA) and regulated by the FCA and PRA) Citigroup Centre 33 Canada Square Canary Wharf London E14 5LB Legal Advisers Eversheds Sutherland (International) LLP One Wood Street London EC2V 7WS Baum Financial Services Law Team Grosser Burstah 42 20457 Hamburg Germany Independent Auditor PricewaterhouseCoopers LLP Atria One 144 Morrison Street Edinburgh EH3 8EX Paying and Information Agent in Belgium CACEIS Belgium S.A Avenue du Port 86C B320 1000 Brussels Belgium Representative and Paying Agent in Switzerland BNP Paribas Securities Services, Paris, Succursale de Zurich Selnaustrasse 16 8002 Zurich Switzerland * Calls will be recorded. ** International Financial Data Services (UK) Limited changed its name to DST Financial Services Europe Limited on 15 August 2017. To find out more visit columbiathreadneedle.com Threadneedle Investment Services Limited, ISA Manager, Authorised Corporate Director and Unit Trust Manager. Registered No. 3701768. Registered in England and Wales. Registered Office: Cannon Place, 78 Cannon Street, London EC4N 6AG. Authorised and regulated by the Financial Conduct Authority. Columbia Threadneedle Investments is the global brand name of the Columbia and Threadneedle group of companies. columbiathreadneedle.com 227385